Raltegravir is an antiretroviral medication belonging to the integrase inhibitor class, utilized primarily in the treatment of HIV-1 infections by blocking the integration of viral DNA into the host genome.… Read more

![Chemical structure of 2,2'-Azobis[2-methyl-propanimidamide] Dihydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2997-92-4-22-Azobis2-methyl-propanimidamide-Dihydrochloride.png&w=3840&q=75)










![Chemical structure of Ethyl 2-[[1-[4-[[[(4-fluorophenyl)methyl]amino]carbonyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-pyrimidinyl]-1-methylethyl]amino]-2-oxoacetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1193687-88-5-Ethyl-2-1-4-4-fluorophenylmethylaminocarbonyl-16-dihydro-5-hydroxy-1-methyl-6-oxo-2-pyrimidinyl-1-methylethylamino-2-oxoacetate.png&w=3840&q=75)






![Chemical structure of N-(4-Fluorobenzyl)-5-methoxy-2-(2-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}propan-2-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-4-Fluorobenzyl-5-methoxy-2-2-5-methyl-134-oxadiazol-2-ylcarbonylaminopropan-2-yl-6-oxo-16-dihydropyrimidine-4-carboxamide.png&w=3840&q=75)





















Raltegravir is an antiretroviral medication belonging to the integrase inhibitor class, utilized primarily in the treatment of HIV-1 infections by blocking the integration of viral DNA into the host genome. This category provides a comprehensive range of high-quality reference standards essential for pharmaceutical laboratories conducting rigorous analytical testing and quality control. The collection includes pharmacopeial and non-pharmacopeial impurities, degradation products, synthetic intermediates, and metabolites necessary for precise impurity profiling and regulatory compliance. Additionally, scientists can access stable isotope labelled compounds to serve as internal standards for mass spectrometry-based assays. These materials are critical for supporting reliable analytical method development, stability testing, and the validation of pharmaceutical processes throughout the drug lifecycle. By providing structurally characterized compounds, this range ensures that researchers can maintain high standards of accuracy and precision in both clinical and developmental applications.